Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Shares Outstanding (Diluted Average): 2021-2022

Historic Shares Outstanding (Diluted Average) for Cullinan Therapeutics (CGEM) over the last 2 years, with Dec 2022 value amounting to $46.6 million.

  • Cullinan Therapeutics' Shares Outstanding (Diluted Average) fell 8.26% to $42.7 million in Q3 2023 from the same period last year, while for Sep 2023 it was $42.7 million, marking a year-over-year decrease of 8.26%. This contributed to the annual value of $46.6 million for FY2022, which is 8.27% up from last year.
  • Per Cullinan Therapeutics' latest filing, its Shares Outstanding (Diluted Average) stood at $46.6 million for FY2022, which was up 8.27% from $43.1 million recorded in FY2021.
  • In the past 5 years, Cullinan Therapeutics' Shares Outstanding (Diluted Average) ranged from a high of $46.6 million in FY2022 and a low of $43.1 million during FY2021.
  • For the 2-year period, Cullinan Therapeutics' Shares Outstanding (Diluted Average) averaged around $44.9 million, with its median value being $44.9 million (2021).
  • Data for Cullinan Therapeutics' Shares Outstanding (Diluted Average) shows a peak YoY climbed of 8.27% (in 2022) over the last 5 years.
  • Over the past 2 years, Cullinan Therapeutics' Shares Outstanding (Diluted Average) (Yearly) stood at $43.1 million in 2021, then increased by 8.27% to $46.6 million in 2022.